A Weekly Injection Could Replace Painful Daily Treatment for Rare Fat Disorder
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.
Medindia12d
Weekly Diabetes Drug Show Promise For Rare Fat Disorder
Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...
Hosted on MSN2mon
New study tracks leptin pulse patterns, a potential clue to understanding obesity
Hormones like cortisol and insulin, which manage stress and blood sugar, are known to follow rhythmic release patterns, adapting to daily cycles. Leptin follows a similar—but unknown —rhythm.
Nature11y
Overexpression of gastric leptin precedes adipocyte leptin during high-fat diet and is linked to 5HT-containing enterochromaffin cells
Plasma leptin and insulin levels in mice were determined with radioimmunoassay kits from Linco Research Inc. (Labodia, France). After the killing, stomach and duodenum were removed and divided ...
Diabetes.co.uk10d
New diabetes drug could replace daily injections for rare disorder
A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...
Pharmabiz4d
CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL
CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...
technologynetworks13d
Weekly Injection Could Replace Painful Daily Treatments for Fat Disorder
A weekly injection of diabetes medication could replace painful daily hormone shots for patients with a rare form of lipodystrophy.